Dr. Hopson studies various medical conditions, particularly those requiring surgical interventions like hernias and advanced cancers. He explores the effectiveness of robotic-assisted surgeries, such as for hernia repairs, and examines treatment patterns for cancer patients, including those with lung cancer and follicular lymphoma. Additionally, his research looks at how artificial intelligence can improve medical education for future healthcare providers. By analyzing patient experiences and treatment costs, Dr. Hopson aims to improve healthcare delivery and outcomes for patients dealing with complex conditions.
Key findings
In a study of the Hugo robotic surgery for hernia repairs, 100% of 193 procedures were successful, and complications were 0% for inguinal hernias and 2.1% for ventral hernias.
The PANDA-PLUS dataset enhanced prostate cancer diagnosis by leading to more consistent cancer grading, reducing errors compared to previous datasets.
In a survey of cancer patients, nearly half reported an average of 14 unhealthy days in the past month, with those suffering from pain experiencing 83% more unhealthy days.
Patients with depression and associated overactive bladder had healthcare costs 13% higher than those without overactive bladder, indicating a significant economic burden.
Among lung cancer patients, those who started guideline-recommended treatment had a slight improvement in survival chances, with a 28.8% death rate in those who did not follow guidelines compared to 23.2% who did.
Frequently asked questions
Does Dr. Hopson study hernias?
Yes, he researches hernia repair techniques, particularly using robotic-assisted surgery.
What cancer treatments has Dr. Hopson researched?
He has explored treatment patterns for various cancers, focusing on advanced non-small cell lung cancer and follicular lymphoma.
Is Dr. Hopson's work relevant to cancer patients?
Yes, his research identifies challenges and treatment patterns that significantly affect cancer patients' quality of life and outcomes.
What is the PANDA-PLUS dataset?
It is a new dataset developed by Dr. Hopson that improves the quality of prostate cancer images for better diagnosis and treatment.
How does Dr. Hopson's research impact healthcare providers?
His findings help healthcare providers make informed treatment decisions to enhance patient outcomes and manage healthcare costs better.
Publications in plain English
PANDA-PLUS: Improved dataset of prostate whole slide images from PANDA Challenge with pixel-level expert annotations.
2026
Journal of pathology informatics
Hopson S, Mildon C, Kubalek C, Ebbert J, Vance R +3 more
Plain English This study created a new dataset called PANDA-PLUS that contains 546 high-quality prostate cancer images with detailed pixel-level annotations, which are much more precise than the labels in the previous PANDA dataset. The research found that the new dataset leads to more consistent and accurate grading of cancer severity, particularly showing that grades were often lower when using PANDA-PLUS, which helps reduce errors that were present in the earlier dataset. This matters because improved and reliable data can help train better AI systems for detecting prostate cancer, potentially improving diagnosis and treatment for patients.
Who this helps: This helps doctors, especially pathologists who diagnose prostate cancer.
Inguinal and Ventral Hernia Repair with the Hugo Robotic-Assisted Surgery System: A Prospective, Single-arm, Clinical Trial.
2026
Annals of surgery
Greenberg JA, Malcher F, Panchal A, Bianco F, Petro C +11 more
Plain English This study looked at the effectiveness and safety of a new robotic surgery system called Hugo for repairing inguinal and ventral hernias in 206 adults. The results showed that the surgery was completely successful in all 193 patients who underwent the procedure, with no need to switch to traditional surgery methods. Additionally, complications were very low, at 0% for inguinal hernias and 2.1% for ventral hernias.
Who this helps: Patients needing hernia repair surgery.
Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors.
2025
The oncologist
Naidoo J, Johnson DB, Doran C, Wang Y, Zhang Y +7 more
Plain English This study looked at how severe immune-related side effects (called s-irAEs) affect patients with advanced non-small cell lung cancer who are treated with immune checkpoint inhibitors (ICIs). It found that 8.6% of patients experienced these side effects, and those who needed stronger treatments like hospitalization or corticosteroids faced much higher risks of dying—up to 61% more likely to die compared to those who managed their side effects differently. Understanding these risks is crucial because it can help doctors make better decisions on how to treat these patients and improve their survival chances.
Who this helps: This benefits patients undergoing treatment for advanced non-small cell lung cancer and their doctors.
Enhancing AI literacy in undergraduate pre-medical education through student associations: an educational intervention.
2025
BMC medical education
Hopson S, Mildon C, Hassard K, Kubalek C, Laverty L +2 more
Plain English This study looked at how an extracurricular program called the AI in Medicine Association (AIM) helped pre-medical students learn about artificial intelligence (AI) in healthcare. After four weeks of training, students in the AIM program showed major improvements in their understanding of AI and its use in diagnosing diseases. Specifically, their scores increased significantly, with some measures showing improvements as high as 4.74 times better than before. This is important because it shows that programs like AIM can effectively fill the gap in AI education for future doctors.
Who this helps: This helps pre-medical students who want to better understand AI in medicine.
Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
2023
Advances in therapy
Hopson S, Gibbs LR, Syed S, Low R, McClung L +1 more
Plain English This study looked at how patients newly diagnosed with psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa — especially those who also had a history of other inflammatory conditions — were treated and the costs involved. Out of over 298,000 patients, treatment costs were significant, with around 53% of patients with psoriatic arthritis also being diagnosed with another condition. This matters because it shows that patients often face high healthcare costs and require coordinated management of multiple conditions rather than treating each one separately.
Who this helps: This helps patients with chronic inflammatory diseases and their healthcare providers.
Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis.
2022
Journal of health economics and outcomes research
Huntington SF, Appukkuttan S, Wang W, Du Y, Hopson S +1 more
Plain English This study looked at how patients with follicular lymphoma, a type of slow-growing cancer, are treated in the U.S. Researchers analyzed data from 4,232 patients and found that the average time to start treatment after diagnosis is 50 days. Most first treatments involved the drug rituximab, used alone or with other medications, and many patients ended up using only one treatment line over several years.
Who this helps: This information benefits doctors and patients by providing insights into current treatment practices for follicular lymphoma.
Ultrasound-based criteria for adequate peripheral venous access in therapeutic apheresis procedures.
2021
Journal of clinical apheresis
Salazar E, Gowani F, Segura F, Passe H, Seamster L +12 more
Plain English This study looked at how to determine if a patient's arm vein is good enough for apheresis procedures, which are medical procedures that filter blood to remove harmful substances. By using ultrasound measurements, researchers found that 96% of procedures went smoothly when the veins met their established criteria. This is important because it shows that using ultrasound can help safely avoid central catheters, which carry more risks.
Who this helps: This helps patients undergoing apheresis by making the procedure safer and more comfortable.
Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam.
2020
Journal of drugs in dermatology : JDD
Williamson T, LaRose A, Cameron J, Lott J, Eaddy M +3 more
Plain English This study compared how satisfied patients are with different treatments for rosacea: azelaic acid foam, metronidazole cream, and metronidazole gel. It found that patients using the foam experienced fewer concerns about treatment effectiveness and side effects, with only 4% worried about efficacy compared to 54% for the gel and 61% for the cream. The foam was also linked to a higher tolerance for side effects, showing that even though patients reported more concerns about cost, they had a better overall experience.
Who this helps: Patients dealing with rosacea.
Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case-Control Cohort Analysis.
2020
Advances in therapy
Shiozawa A, Hopson S, Fuldeore R, Stoelzel M, Ng D +1 more
Plain English This study examined how having an overactive bladder (OAB) affects healthcare costs and work productivity in people with depression. It found that patients with depression and OAB had 13% higher costs related to their depression—averaging about $1,796 compared to $1,597 for those without OAB. Additionally, 21.3% of patients with both conditions used short-term disability benefits, compared to 16.9% without OAB, indicating greater work-related challenges.
Who this helps: This research benefits patients with depression and OAB, as well as their healthcare providers.
Using the Healthy Days Measure to Assess Factors Associated with Poor Health-Related Quality of Life for Patients with Metastatic Breast, Lung, or Colorectal Cancer Enrolled in a Medicare Advantage Health Plan.
2019
Population health management
Casebeer AW, Antol DD, Hopson S, Khoury R, Renda A +5 more
Plain English This study looked at how different symptoms affect the quality of life for patients with advanced breast, lung, or colorectal cancer who are on Medicare. Researchers found that nearly half of the patients reported experiencing a lot of unhealthy days, with an average of 14 unhealthy days in the past month. Specifically, those with pain had 83% more unhealthy days, and those with fatigue had 104% more unhealthy days compared to patients without these symptoms. Improving cancer-related symptoms like pain and fatigue could help these patients feel better.
Who this helps: This helps cancer patients by highlighting ways to improve their health-related quality of life.
Plain English This study looked at how well a special patch called the Parietex Composite Ventral Patch worked in repairing abdominal hernias in 126 patients over two years. Researchers found that only 3% of patients had their hernia come back, and pain levels dropped significantly from an average of 2 to nearly zero after one month, with 99% of patients being satisfied with the results after two years. This is important because it shows that this patch is a reliable option for safely repairing small hernias with good long-term outcomes.
Who this helps: This helps patients with umbilical and epigastric hernias looking for effective surgical repair options.
What Does a Single-Item Measure of Job Stressfulness Assess?
2019
International journal of environmental research and public health
Houdmont J, Jachens L, Randall R, Hopson S, Nuttall S +1 more
Plain English This study looked at how people rate their job stress using a simple question about overall job stressfulness. Researchers interviewed 55 full-time workers and found that many people based their ratings on factors like heavy workloads and poor working conditions, with 40% of participants considering multiple influences when answering. Understanding these factors is important because it helps improve how job stress is measured and managed in workplaces.
Who this helps: This helps employers and occupational health professionals better understand and address job stress for their employees.
Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States?
2018
Journal of medical economics
Hopson S, Casebeer A, Stemkowski S, Antol DD, Tao Z +4 more
Plain English This study looked at how the location where cancer patients receive their infusion therapy—either in a hospital outpatient setting or a doctor's office—affects their treatment, costs, and the quality of care. Researchers found that patients treated in hospitals received fewer treatment sessions and shorter therapy durations but ended up spending about 15% more overall on healthcare ($55,965) compared to those treated in doctors' offices ($48,439). Despite the differences in costs and treatment length, the quality of care at the end of life was similar between the two settings.
Who this helps: This information benefits patients and doctors by highlighting cost differences and treatment patterns in cancer care settings.
The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.
2018
Journal of managed care & specialty pharmacy
Casebeer A, Antol DD, DeClue RW, Hopson S, Li Y +6 more
Plain English This study looked at how starting treatment based on medical guidelines affects outcomes and costs for patients with advanced non-small cell lung cancer. It found that 75.5% of patients began guideline-recommended treatment. Among those who did not, 28.8% died within six months, compared to 23.2% who did start treatment, indicating that those who followed guidelines had slightly better survival outcomes.
Who this helps: This research benefits doctors and patients by highlighting the importance of following treatment guidelines in improving outcomes for lung cancer patients.
The relationship between comorbidity medication adherence and health related quality of life among patients with cancer.
2018
Journal of patient-reported outcomes
Drzayich Antol D, Waldman Casebeer A, Khoury R, Michael T, Renda A +6 more
Plain English This study looked at how sticking to medications for health issues other than cancer affects the quality of life for older cancer patients. Researchers found that patients who were less consistent with their comorbidity medications reported 23.4% more unhealthy days compared to those who took their medications regularly. This matters because improving adherence to these medications could help cancer patients feel better and maintain a higher quality of life during treatment.
Who this helps: This helps older cancer patients dealing with additional health issues.
Retracted: Using the Healthy Days Measure to Assess Factors Associated with Poor Health-Related Quality of Life for Patients with Metastatic Breast, Lung, or Colorectal Cancer Enrolled in a Medicare Advantage Health Plan.
2018
Population health management
Casebeer AW, Antol DD, Hopson S, Khoury R, Renda A +5 more
Plain English This paper looked at how factors affect the quality of life for patients with advanced breast, lung, or colorectal cancer who are part of a Medicare Advantage health plan. The authors decided to retract the paper to remove references to a specific medication adherence scale due to a licensing issue, but this change does not affect the study's findings or conclusions. This research is important as it helps understand how certain factors can impact the well-being of cancer patients, which can lead to better support and care strategies.
Who this helps: This helps patients dealing with cancer and healthcare providers working with them.
Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients.
2017
International journal of chronic obstructive pulmonary disease
Dhamane AD, Schwab P, Hopson S, Moretz C, Annavarapu S +3 more
Plain English This study looked at how well patients with chronic obstructive pulmonary disease (COPD) stick to their medications, especially when they also take medications for other health issues. It found that 79.2% of the COPD patients studied didn’t follow their medication plan for COPD, with an average adherence rate of only 47%. Moreover, their adherence to COPD medications was positively related to how well they followed their other medication plans, meaning that managing multiple medications doesn’t seem to make it harder to take COPD meds.
Who this helps: This benefits COPD patients and their healthcare providers.
A multicenter prospective study of patients undergoing open ventral hernia repair with intraperitoneal positioning using the monofilament polyester composite ventral patch: interim results of the PANACEA study.
Plain English This study looked at how effective and safe a specific type of mesh (the Parietex Composite Ventral Patch) is for repairing ventral hernias, which are commonly found in the umbilical area. Out of 126 patients, the recurrence rate of hernias after one year was low at 2.8%, and patients experienced a significant drop in pain from an average score of 2.1 before surgery to just 0.5 one month after. The results indicate that this mesh is easy for surgeons to use and leads to high patient satisfaction, making it a promising option for hernia repairs.
Who this helps: This helps patients who need hernia repair surgery.
BAF180: Its Roles in DNA Repair and Consequences in Cancer.
2017
ACS chemical biology
Hopson S, Thompson MJ
Plain English This study focused on a protein called BAF180 and its role in repairing DNA, which is crucial for preventing cancer. Researchers found that mutations in the gene associated with BAF180 are linked to over 30 types of cancers, such as kidney, breast, and bladder cancer, with most mutations leading to the loss of this important protein. Understanding BAF180's role in DNA repair is crucial because its loss can lead to cancer development.
Who this helps: This helps cancer patients and doctors by providing insights into potential targets for new treatments.
Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis.
2016
Journal of managed care & specialty pharmacy
Hopson S, Saverno K, Liu LZ, AL-Sabbagh A, Orazem J +2 more
Plain English This study looked at how out-of-pocket costs affect patients starting and continuing treatment with biologic drugs for rheumatoid arthritis (RA). It found that 18.2% of patients abandoned their initial prescriptions, but this rate soared to 32.7% for those facing high costs over $550. The results show that higher costs significantly discourage patients from starting or refilling their RA medications, which is crucial since these drugs are vital for managing the disease effectively.
Who this helps: Patients with rheumatoid arthritis.
Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project.
2008
American journal of kidney diseases : the official journal of the National Kidney Foundation
Hopson S, Frankenfield D, Rocco M, McClellan W
Plain English This study looked at why different groups of people use catheters for hemodialysis and found significant differences based on race, sex, and where they live. Of nearly 8,500 patients, about 27% used a catheter; among them, 61% used it for long-term reasons, like not having a suitable blood vessel available. Understanding these differences is important because it can help healthcare providers find ways to reduce the reliance on catheters, which can lead to fewer complications for patients.
Who this helps: Patients needing hemodialysis, especially those at risk for complications from catheters.
Dana Drzayich Antol Stephen Stemkowski Raya Khoury Todd Michael Andrew Renda Aparna Parikh Mikele Bunce Adrianne Waldman Casebeer Alisha Stein Carson Mildon
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.